Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SEROTYPE DISTRIBUTION AND ANTIBIOTIC SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE CAUSING INVASIVE DISEASES IN CHILDREN AND ADULTS: A LABORATORY- BASED MULTICENTER RETROSPECTIVE STUDY

NCT01810861 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01810861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01810861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SEROTYPE DISTRIBUTION AND ANTIBIOTIC SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE CAUSING INVASIVE DISEASES IN CHILDREN AND ADULTS: A LABORATORY- BASED MULTICENTER RETROSPECTIVE STUDY
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
January 4, 2013
Completion date
July 31, 2019
Enrollment
922 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal diseases